PAVmed (PAVM) Net Income Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4,440.69% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | -341.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -341.42% |
| Jun 30, 2025 | 17.37% |
| Mar 31, 2025 | 200.60% |
| Dec 31, 2024 | 106.56% |
| Jun 30, 2024 | 16.64% |
| Mar 31, 2024 | 16.67% |
| Dec 31, 2023 | 29.16% |
| Sep 30, 2023 | 27.34% |
| Jun 30, 2023 | 38.52% |
| Mar 31, 2023 | -13.15% |
| Dec 31, 2022 | -24.86% |
| Sep 30, 2022 | -118.99% |
| Jun 30, 2022 | -129.68% |
| Mar 31, 2022 | -94.19% |
| Dec 31, 2021 | -112.54% |
| Sep 30, 2021 | -132.69% |
| Jun 30, 2021 | -116.80% |
| Mar 31, 2021 | 32.20% |
| Dec 31, 2020 | -41.27% |
| Sep 30, 2020 | -79.58% |
| Jun 30, 2020 | -56.30% |
| Mar 31, 2020 | -302.56% |
| Dec 31, 2019 | 5.32% |
| Sep 30, 2019 | 0.23% |
| Jun 30, 2019 | 27.35% |
| Mar 31, 2019 | -31.10% |
| Dec 31, 2018 | -895.80% |
| Sep 30, 2018 | 36.08% |
| Jun 30, 2018 | -420.01% |
| Mar 31, 2018 | 33.83% |
| Dec 31, 2017 | 150.85% |
| Sep 30, 2017 | -165.94% |
| Jun 30, 2017 | 24.72% |
| Mar 31, 2017 | -512.74% |